14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.13 $4.97 Wednesday, 1st May 2024 ALDX stock ended at $4.20. This is 6.60% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.46% from a day low at $3.96 to a day high of $4.30.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Jan 14, 2022 $3.58 $3.78 $3.55 $3.78 660 800
Jan 13, 2022 $3.76 $3.83 $3.35 $3.66 1 126 900
Jan 12, 2022 $3.80 $3.88 $3.69 $3.73 776 700
Jan 11, 2022 $3.86 $3.96 $3.70 $3.81 1 157 900
Jan 10, 2022 $3.84 $3.86 $3.64 $3.84 900 500
Jan 07, 2022 $3.89 $4.09 $3.84 $3.85 619 100
Jan 06, 2022 $3.94 $4.05 $3.80 $3.94 1 108 900
Jan 05, 2022 $4.17 $4.30 $3.90 $3.90 1 313 300
Jan 04, 2022 $4.30 $4.40 $4.14 $4.24 842 914
Jan 03, 2022 $4.06 $4.29 $3.93 $4.27 1 004 853
Dec 31, 2021 $4.16 $4.18 $3.94 $4.00 1 341 061
Dec 30, 2021 $4.05 $4.23 $3.94 $4.06 1 124 077
Dec 29, 2021 $4.10 $4.17 $3.95 $4.01 1 174 169
Dec 28, 2021 $4.14 $4.47 $4.04 $4.06 1 190 856
Dec 27, 2021 $4.17 $4.23 $3.98 $4.08 1 878 401
Dec 23, 2021 $3.83 $4.22 $3.82 $4.17 2 355 758
Dec 22, 2021 $3.46 $3.93 $3.37 $3.84 6 719 590
Dec 21, 2021 $4.00 $4.07 $3.40 $3.50 13 094 984
Dec 20, 2021 $6.93 $7.26 $6.84 $7.13 1 991 754
Dec 17, 2021 $6.80 $7.33 $6.69 $7.04 2 958 363
Dec 16, 2021 $7.11 $7.14 $6.66 $6.77 826 060
Dec 15, 2021 $6.75 $7.15 $6.51 $7.10 1 050 196
Dec 14, 2021 $6.95 $7.05 $6.70 $6.76 807 347
Dec 13, 2021 $6.89 $7.27 $6.70 $7.01 797 943
Dec 10, 2021 $7.06 $7.17 $6.89 $6.93 478 870
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT